Metris et al. BMC Genomics 2011, 12:535 http://www.biomedcentral.com/1471-2164/12/535 34. Carlone GM, Anet FA: Detection of menaquinone-6 and a novel methyl- substituted menaquinone-6 in Campylobacter jejuni and Campylobacter fetus subsp. fetus. J Gen Microbiol 1983, 129:3385-3393. 35. Hiratsuka T, Itoh N, Seto H, Dairi T: Enzymatic properties of futalosine hydrolase, an enzyme essential to a newly identified menaquinone biosynthetic pathway. Biosci Biotechnol Biochem 2009, 73:1137-1141. 36. Dickgiesser N, Czylwik D: Chemically defined media for auxotyping of Campylobacter jejuni. Zentralbl Bakteriol Mikrobiol Hyg A 1985, 260:57-64. 37. Leach S, Harvey P, Wali R: Changes with growth rate in the membrane lipid composition of and amino acid utilization by continuous cultures of Campylobacter jejuni. J Appl Microbiol 1997, 82:631-640. 38. Martinez-Rodriguez A, Mackey BM: Physiological changes in Campylobacter jejuni on entry into stationary phase. Int J Food Microbiol 2005, 101:1-8. 39. Lambert MA, Patton CM, Barrett TJ, Moss CW: Differentiation of Campylobacter and Campylobacter-Like Organisms by Cellular Fatty-Acid Composition. Journal of Clinical Microbiology 1987, 25:706-713. 40. Moss CW, Kai A, Lambert MA, Patton C: Isoprenoid quinone content and cellular fatty acid composition of Campylobacter species. J Clin Microbiol 1984, 19:772-776. 41. Hoffman PS, Goodman TG: Respiratory Physiology and Energy- Conservation Efficiency of Campylobacter jejuni. Journal of Bacteriology 1982, 150:319-326. 42. Mohammed KA, Miles RJ, Halablab MA: The pattern and kinetics of substrate metabolism of Campylobacter jejuni and Campylobacter coli. Lett Appl Microbiol 2004, 39:261-266. 43. Westfall HN, Rollins DM, Weiss E: Substrate utilization by Campylobacter jejuni and Campylobacter coli. Appl Environ Microbiol 1986, 52:700-705. 44. Holmes K, Tavender TJ, Winzer K, Wells JM, Hardie KR: AI-2 does not function as a quorum sensing molecule in Campylobacter jejuni during exponential growth in vitro. BMC Microbiol 2009, 9:214. 45. Palyada K, Sun YQ, Flint A, Butcher J, Naikare H, Stintzi A: Characterization of the oxidative stress stimulon and PerR regulon of Campylobacter jejuni. BMC Genomics 2009, 10:481. 46. Reid AN, Pandey R, Palyada K, Naikare H, Stintzi A: Identification of Campylobacter jejuni genes involved in the response to acidic pH and stomach transit. Appl Environ Microbiol 2008, 74:1583-1597. 47. Wright JA, Grant AJ, Hurd D, Harrison M, Guccione EJ, Kelly DJ, Maskell DJ: Metabolite and transcriptome analysis of Campylobacter jejuni in vitro growth reveals a stationary-phase physiological switch. Microbiology 2009, 155:80-94. 48. Parrish JR, Yu J, Liu G, Hines JA, Chan JE, Mangiola BA, Zhang H, Pacifico S, Fotouhi F, DiRita VJ, et al: A proteome-wide protein interaction map for Campylobacter jejuni. Genome Biol 2007, 8:R130. 49. Crossley RA, Gaskin DJ, Holmes K, Mulholland F, Wells JM, Kelly DJ, van Vliet AH, Walton NJ: Riboflavin biosynthesis is associated with assimilatory ferric reduction and iron acquisition by Campylobacter jejuni. Appl Environ Microbiol 2007, 73:7819-7825. 50. Arakaki AK, Tian W, Skolnick J: High precision multi-genome scale reannotation of enzyme function by EFICAz. BMC Genomics 2006, 7:315. 51. Claudel-Renard C, Chevalet C, Faraut T, Kahn D: Enzyme-specific profiles for genome annotation: PRIAM. Nucleic Acids Res 2003, 31:6633-6639. 52. EFICAz. [http://cssb2.biology.gatech.edu/EFICAz/data/bac/cje_eficaz_4ec. html]. 53. PRIAM. [http://www.priam.prabi.fr/REL_MAY11/index_may11.html]. 54. Overbeek R, Begley T, Butler RM, Choudhuri JV, Chuang HY, Cohoon M, de Crecy-Lagard V, Diaz N, Disz T, Edwards R, et al: The subsystems approach to genome annotation and its use in the project to annotate 1000 genomes. Nucleic Acids Res 2005, 33:5691-5702. 55. The Seed. [http://seed-viewer.theseed.org/seedviewer.cgi]. 56. Schuster S, Pfeiffer T, Fell DA: Is maximization of molar yield in metabolic networks favoured by evolution? J Theor Biol 2008, 252:497-504. 57. Papp B, Teusink B, Notebaart RA: A critical view of metabolic network adaptations. HFSP J 2009, 3:24-35. 58. van Vliet AH, Wooldridge KG, Ketley JM: Iron-responsive gene regulation in a campylobacter jejuni fur mutant. J Bacteriol 1998, 180:5291-5298. 59. Jeong H, Tombor B, Albert R, Oltvai ZN, Barabasi AL: The large-scale organization of metabolic networks. Nature 2000, 407:651-654. 60. Yu H, Kim PM, Sprecher E, Trifonov V, Gerstein M: The importance of bottlenecks in protein networks: correlation with gene essentiality and expression dynamics. PLoS Comput Biol 2007, 3:e59. Page 14 of 14 61. Yu H, Braun P, Yildirim MA, Lemmens I, Venkatesan K, Sahalie J, Hirozane- Kishikawa T, Gebreab F, Li N, Simonis N, et al: High-quality binary protein interaction map of the yeast interactome network. Science 2008, 322:104-110. 62. Solé R, Pastor-satorras R, Smith E, Kepler T: A model of large-scale proteome evolution. Advances in Complex Systems 2002, 5:43-54. 63. Deeds EJ, Ashenberg O, Shakhnovich EI: A simple physical model for scaling in protein-protein interaction networks. Proc Natl Acad Sci USA 2006, 103:311-316. 64. Davies GM, Barrett-Bee KJ, Jude DA, Lehan M, Nichols WW, Pinder PE, Thain JL, Watkins WJ, Wilson RG: (6S)-6-fluoroshikimic acid, an antibacterial agent acting on the aromatic biosynthetic pathway. Antimicrob Agents Chemother 1994, 38:403-406. 65. Vianna CP, de Azevedo WF Jr: Identification of new potential Mycobacterium tuberculosis shikimate kinase inhibitors through molecular docking simulations. J Mol Model 2011. 66. Zucko J, Dunlap WC, Shick JM, Cullum J, Cercelet F, Amin B, Hammen L, Lau T, Williams J, Hranueli D, Long PF: Global genome analysis of the shikimic acid pathway reveals greater gene loss in host-associated than in free-living bacteria. BMC Genomics 2010, 11:628. 67. Gerdes SY, Scholle MD, Campbell JW, Balazsi G, Ravasz E, Daugherty MD, Somera AL, Kyrpides NC, Anderson I, Gelfand MS, et al: Experimental determination and system level analysis of essential genes in Escherichia coli MG1655. J Bacteriol 2003, 185:5673-5684. 68. Joyce AR, Reed JL, White A, Edwards R, Osterman A, Baba T, Mori H, Lesely SA, Palsson BO, Agarwalla S: Experimental and computational assessment of conditionally essential genes in Escherichia coli. J Bacteriol 2006, 188:8259-8271. 69. KEGG. [http://www.genome.jp/kegg-bin/show_organism? menu_type=pathway_maps&org=cje]. 70. BioCyc. [http://biocyc.org/CJEJ192222/organism-summary]. 71. Reed JL, Famili I, Thiele I, Palsson BO: Towards multidimensional genome annotation. Nat Rev Genet 2006, 7:130-141. 72. Guccione E, Leon-Kempis Mdel R, Pearson BM, Hitchin E, Mulholland F, van Diemen PM, Stevens MP, Kelly DJ: Amino acid-dependent growth of Campylobacter jejuni: key roles for aspartase (AspA) under microaerobic and oxygen-limited conditions and identification of AspB (Cj0762), essential for growth on glutamate. Mol Microbiol 2008, 69:77-93. 73. Palsson BO, (Ed.): Systems Biology. Cambridge University Press; 2006. 74. Becker SA, Feist AM, Mo ML, Hannum G, Palsson BO, Herrgard MJ: Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox. Nat Protoc 2007, 2:727-738. 75. Zimbro MJ, Power DA, (Eds.): Difco & BBL Manual. 2003. 76. Raghunathan A, Reed J, Shin S, Palsson B, Daefler S: Constraint-based analysis of metabolic capacity of Salmonella typhimurium during host- pathogen interaction. BMC Syst Biol 2009, 3:38. 77. Varma A, Palsson BO: Stoichiometric flux balance models quantitatively predict growth and metabolic by-product secretion in wild-type Escherichia coli W3110. Appl Environ Microbiol 1994, 60:3724-3731. 78. glpk. [http://www.gnu.org/software/glpk/glpk.html]. 79. Gaskin DJ, van Vliet AH: Random mutagenesis strategies for Campylobacter and Helicobacter species. Methods Mol Biol 2010, 634:37-52. doi:10.1186/1471-2164-12-535 Cite this article as: Metris et al.: In vivo and in silico determination of essential genes of Campylobacter jejuni. BMC Genomics 2011 12:535.